Vanguard Group’s Intellia Therapeutics NTLA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $102M | Buy |
|
|||||
|
2025
Q1 | $76.4M | Buy |
|
|||||
|
2024
Q4 | $119M | Buy |
|
|||||
|
2024
Q3 | $198M | Buy |
|
|||||
|
2024
Q2 | $204M | Buy |
|
|||||
|
2024
Q1 | $250M | Buy |
|
|||||
|
2023
Q4 | $255M | Buy |
|
|||||
|
2023
Q3 | $259M | Buy |
|
|||||
|
2023
Q2 | $334M | Buy |
|
|||||
|
2023
Q1 | $303M | Buy |
|
|||||
|
2022
Q4 | $272M | Buy |
|
|||||
|
2022
Q3 | $370M | Buy |
|
|||||
|
2022
Q2 | $337M | Buy |
|
|||||
|
2022
Q1 | $465M | Sell |
|
|||||
|
2021
Q4 | $762M | Buy |
|
|||||
|
2021
Q3 | $852M | Buy |
|
|||||
|
2021
Q2 | $976M | Buy |
|
|||||
|
2021
Q1 | $448M | Buy |
|
|||||
|
2020
Q4 | $279M | Buy |
|
|||||
|
2020
Q3 | $87M | Buy |
|
|||||
|
2020
Q2 | $89.5M | Buy |
|
|||||
|
2020
Q1 | $42.7M | Sell |
|
|||||
|
2019
Q4 | $51.7M | Buy |
|
|||||
|
2019
Q3 | $46.1M | Buy |
|
|||||
|
2019
Q2 | $52.1M | Buy |
|
|||||
|
2019
Q1 | $48M | Buy |
|
|||||
|
2018
Q4 | $37.5M | Buy |
|
|||||
|
2018
Q3 | $75.9M | Buy |
|
|||||
|
2018
Q2 | $64.7M | Buy |
|
|||||
|
2018
Q1 | $42.4M | Buy |
|
|||||
|
2017
Q4 | $35.3M | Buy |
|
|||||
|
2017
Q3 | $26M | Buy |
|
|||||
|
2017
Q2 | $16M | Buy |
|
|||||
|
2017
Q1 | $12.7M | Buy |
|
|||||
|
2016
Q4 | $11.4M | Buy |
|
|||||
|
2016
Q3 | $7.48M | Buy |
|
|||||
|
2016
Q2 | $8.89M | Buy |
|